DLK1 and cancer: It was found by Li et al. [35] that, expressed in malignancies, Delta-like 1 homologue (DLK1) enhancing the tumourigenicity and stemness of cancer cell potentially becomes a molecule target for treatments against cancer stem or progenitor cells.